Proda Biotech LLC

InLighta Biosciences LLC, based in Marietta, GA, is pioneering advancements in Magnetic Resonance Imaging (MRI) contrast agents aimed at enhancing early disease detection, particularly for cancer and other serious conditions. Their innovative precision MRI technology addresses the limitations of conventional diagnostic methods, enabling faster monitoring of disease progression and improved therapeutic evaluation. The company is advancing the ProCA series of contrast agents, which includes protein-based, blood pool, and targeted agents tailored for specific biomarkers. Through these developments, InLighta Biosciences strives to transform the landscape of medical diagnostics, offering hope for earlier intervention and treatment options for patients. Generated from the website

Radyus Research, Inc., based in Atlanta, GA, is a comprehensive drug development partner that integrates scientific expertise, strategic counsel, and operational execution to meet the unique needs of its clients. With a focus on streamlining processes and efficiently managing programs from preclinical to clinical stages, Radyus supports biotech companies and seed venture funds in accelerating their drug development milestones. Boasting an experienced team from top pharmaceutical backgrounds, Radyus offers tailored services that include lead optimization, regulatory strategy, and clinical study design. Since its inception, the company has successfully provided innovative solutions for over 50 clients across 12 countries, continuously refining its approach to empower growth in drug and business development. Generated from the website

Founded in 2001, GeoVax Labs is a biotechnology company that develops a range of human vaccines for diseases related to HIV-1 and other infectious agents. It provides AIDS vaccines for global markets, as well as manufactures and tests vaccinations. The company also conducts human trials for vaccine safety and effectiveness. GeoVax Labs organizes scientific programs, as well as conducts pre-clinical and translational research. In addition, it organizes clinical trials and has received the Safe to Proceed status from the U.S. Food and Drug Administration.